Aerocrine Appoints New CEO.SOLNA Solna (sōl`nä), city (1995 pop. 54,160), Stockholm co., E Sweden, an industrial suburb of Stockholm. Manufactures include machinery, electrical goods, paper, and chocolate. , Sweden -- Aerocrine today announced the appointment of Paul de Potocki to the position of President and Chief Executive Officer, Aerocrine AB, effective from February 1, 2007. Paul succeeds Thomas (language) Thomas - A language compatible with the language Dylan(TM). Thomas is NOT Dylan(TM). The first public release of a translator to Scheme by Matt Birkholz, Jim Miller, and Ron Weiss, written at Digital Equipment Corporation's Cambridge Research Laboratory runs Almesjo who has led the development of Aerocrine since its foundation, and who is now moving on to assignments outside the company. Paul joins Aerocrine after serving as Senior Vice President, Commercial and Strategic Development at Biovitrum AB, a $740 million biopharma company, and a member of Biovitrum's executive management team. Prior to joining Biovitrum, he has served as Executive Vice President, Strategic Marketing at Fresenius Kabi, a subsidiary of the German health care group Fresenius AG. Paul has also spent five years at Pharmacia where he held the position of Divisional Vice President, Global Sales and Strategic Marketing, and he has held various international commercial management positions within the Unilever group in Europe. "Aerocrine is entering a new stage of development with accelerated market acceptance of the important role Aerocrine's nitric oxide nitric oxide or nitrogen monoxide, a colorless gas formed by the combustion of nitrogen and oxygen as given by the reaction: energy + N2 + O2 → 2NO; m.p. −163.6°C;; b.p. −151.8°C;. monitoring systems may play in asthma asthma (ăz`mə, ăs`–), chronic inflammatory respiratory disease characterized by periodic attacks of wheezing, shortness of breath, and a tight feeling in the chest. A cough producing sticky mucus is symptomatic. management," said Mats Fischier, chairman of the board. "Paul's significant industry experience makes him exceptionally qualified to meet the challenges of achieving our goal of bringing Aerocrine's products to the benefit of patients in international markets." About Aerocrine Aerocrine AB is a clinically based medical technology corporation dedicated to improved asthma management and care. The company is marketing NIOX[R] on a worldwide basis and is also marketing NIOX MINO[R], representing a new generation of hand-held devices, in Europe. Both products are tailored for rapid, non-invasive Non-invasive A procedure that does not penetrate the body. Mentioned in: Multiple-Gated Acquisition Scan non-invasive 1. not penetrating the skin, e.g. a non-invasive test. 2. control of the inflammatory status in the airways airways Anatomy The 'pipes'–trachea, bronchi, bronchioles–through which air passes to and from the alveoli. See Small airways. and may play a critical role for a more efficient diagnosis, treatment and monitoring of asthma patients. Aerocrine is located in Sweden with wholly owned subsidiaries Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. in the US, UK and Germany. This information was brought to you by Waymaker http://www.waymaker.net |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion